Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jorge Nadal"'
Autor:
Verónica Fabiano, Pablo Mandó, Manglio Rizzo, Carolina Ponce, Federico Coló, Martín Loza, Jose Loza, Mora Amat, Daniel Mysler, María Victoria Costanzo, Adrián Nervo, Jorge Nadal, Florencia Perazzo, Reinaldo Chacón
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 639-646 (2020)
PURPOSE Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables. PATIENTS AND METHODS We performed a retrospe
Externí odkaz:
https://doaj.org/article/bd68930b829f4c82925e350c5f266a10
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::792840969b0a931891d762a69e68f1c7
https://doi.org/10.7759/cureus.34514
https://doi.org/10.7759/cureus.34514
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1a83630b25b7c1066f799310199703
https://doi.org/10.7759/cureus.31480
https://doi.org/10.7759/cureus.31480
Autor:
Luisina Bruno, Alexis Ostinelli, Federico Waisberg, Diego Enrico, Carolina Ponce, Sergio Rivero, Albano Blanco, Martín Zarba, Martín Loza, Verónica Fabiano, Mora Amat, María Teresa Pombo, Laura Noro, Matías Chacón, Federico Coló, Reinaldo Chacón, Jorge Nadal, Adrián Nervo, Victoria Costanzo
Publikováno v:
JCO Precision Oncology.
PURPOSE In recent years, unprecedented benefits have been observed with the development of cyclin-dependent kinase (CDK) 4 and 6 inhibitors for the treatment of hormone receptor–positive/human epidermal growth factor receptor 2–negative metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c6ff7a0c59759b5dcd8f2af975167c
https://doi.org/10.1200/po.21.00140
https://doi.org/10.1200/po.21.00140
Autor:
Jorge Nadal, Carolina Ponce, Daniel C Mysler, Florencia Perazzo, Adrián Nervo, Mora Amat, Verónica Fabiano, Pablo Mandó, Federico Coló, Martín Loza, Jose Loza, MV Costanzo, Reinaldo Chacón, Manglio Rizzo
Publikováno v:
JCO Global Oncology
PURPOSE Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables. PATIENTS AND METHODS We performed a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffd9d7acb4497c08732a5a3eb8f70a0
https://doi.org/10.1200/jgo.19.00228
https://doi.org/10.1200/jgo.19.00228
Autor:
Joyce O'Shaughnessy, Susana Sousa, Josefina Cruz, Lesley Fallowfield, Päivi Auvinen, Catarina Pulido, Ana Cvetanovic, Sharon Wilks, Leonor Ribeiro, Mauricio Burotto, Dirk Klingbiel, Dimitri Messeri, Ari Alexandrou, Peter Trask, Judy Fredriksson, Zuzana Machackova, Ljiljana Stamatovic, Ernesto Korbenfeld, Jorge Nadal, Helio Pinczowski, Felipe J. Cruz, Gustavo Sousa, Aline C. Goncalves, Gisah Guilgen, Antti Jekunen, Winne Yeo, Chi K. Cheng, Hikmat A. Razeq, Fadi Karak, Fadi Farhat, Servando C. Huerta, Brizio M. Jaime, Juan Feregrino, Omar Castillo-Fernandez, Juan C. Alcedo, Maria Dionisio, Salha Bujassoum, Hatoon Bakhraibah, Alvaro R. Lescure, Camilla Wendt, Sara Margolin, Helena G. Björneklett, Michelina Cairo, Shaker Dakhil, Nguyet Le-Lindqwister, Ling Ma, Kristi J. McIntyre, Joyce O’Shaughnessy, Svetislava J. Vukelja, Donald Richards, John Wallmark
Aim: The aim of the study was to assess patient preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) in patients with HER2-positive early breast cancer in PHranceSCa (NCT03674112). Materials a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa4c6a666e370a233289e49fa120291
https://zenodo.org/record/5196150
https://zenodo.org/record/5196150
Autor:
Oller, Jorge Nadal, Borrell, Enrique
Publikováno v:
Population (French Edition), 1961 Jan 01. 16(1), 91-104.
Externí odkaz:
https://www.jstor.org/stable/1526660
Autor:
Carolina Ponce, María Betina Pampena, Estefanía Paula Juliá, Manglio Rizzo, Constanza Pérez de la Puente, Estrella Mariel Levy, Pablo Mandó, Federico Coló, Maria Paula Roberti, Jorge Nadal, Carlos Martin Loza, Jose Mordoh
Publikováno v:
OncoTargets and Therapy. 11:2901-2910
Purpose Breast cancer (BC) is a highly heterogeneous disease presenting a broad range of clinical and molecular characteristics. In the past years, a growing body of evidence demonstrated that immune response plays a significant role in cancer outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ce307908344154c01f7386a65faf2c0
https://doi.org/10.2147/ott.s160911
https://doi.org/10.2147/ott.s160911
Autor:
Carlos Martin Loza, R. D. Chacon, Jose Loza, C Perez de la Puente, Jorge Nadal, Adrian Nervo, Manglio Rizzo, Verónica Fabiano, MV Costanzo, Pablo Mandó, Federico Coló, Carolina Ponce
Publikováno v:
Cancer Research. 78:P6-09
Introduction: ESR1 mutations were described for the first time in 1996 when different tyrosine 537 mutations were found to confer constitutive activation of the receptor, describing this region as a key factor in the ligand regulation of ER transcrip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b965140f5894d669ea47fae769c6206
https://doi.org/10.1158/1538-7445.sabcs17-p6-09-09
https://doi.org/10.1158/1538-7445.sabcs17-p6-09-09
Autor:
MT Pombo, MV Costanzo, Carolina Ponce, R. D. Chacon, Adrian Nervo, Pablo Mandó, Verónica Fabiano, C Perez de la Puente, Carlos Martin Loza, M Maino, Jorge Nadal, Manglio Rizzo, Federico Coló
Publikováno v:
Cancer Research. 77:P6-09
Introduction: Breast cancer is the tumor with highest incidence and mortality in women in Argentina. Hormonal receptors (HR) and HER2 are the most important prognostic and predictive factors. It is suggested that estrogen receptors (ER), progesterone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55012e830a8cbb079b824ae4fa20b3fd
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-40
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-40